AMP-activated protein kinase regulates L-arginine mediated cellular responses

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Mohan, Srinidi ^a   Patel, Harsh ^a   Bolinaga, Jorge ^a   Soekamto, Nathania ^a  

^a UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

AMPK; Endothelial nitric oxide synthase; L Arginine; Nitric oxide; Peroxynitrite; Superoxide

Indexed keywords

2 METHYLANILINE; ARGININE; BENZOXAZOLE DERIVATIVE; CARBON 13; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCEIN; GLUCOSE; GLUCOSE TRANSPORTER 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRITE; OXYGEN; PEROXYNITRITE; SUPEROXIDE;

ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EXPOSURE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR TRANSPORT; LIQUID CHROMATOGRAPHY; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TANDEM MASS SPECTROMETRY; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84878218699     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-40     Document Type: Article

References (50)

1. L-Arginine Medlineplus supplements. Medlineplus 2011 http://www.nlm.nih. gov/medlineplus/druginfo/natural/875.html
2. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K, Am J Cardiol 1997 80 331 333 10.1016/S0002-9149(97)00354-8 9264427
3. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Maxwell AJ, Anderson BE, Cooke JP, Vasc Med 2000 5 11 19 10737151
4. Bednarz K, Am Ende der Welt: eine Reise durch Feuerland und Patagonien. 1. Aufl. edn Berlin: Rowohlt 2004
5. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, Schuler G, J Am Coll Cardiol 2000 35 706 713 10.1016/S0735-1097(99)00602-6 10716474
6. L-arginine availability regulates T-lymphocyte cell-cycle progression. Rodriguez PC, Quiceno DG, Ochoa AC, Blood 2007 109 1568 1573 10.1182/blood-2006-06-031856 17023580
7. Effects of arginine supplementation on mucosal immunity in rats with septic peritonitis. Shang HF, Wang YY, Lai YN, Chiu WC, Yeh SL, Clin Nutr 2004 23 561 569 10.1016/j.clnu.2003.10.005 15297092
8. Effect of L-arginine on intestinal mucosal immune barrier function in weaned pigs after Escherichia coli LPS challenge. Zhu H, Liu Y, Xie X, Huang J, Hou Y, Innate Immun 2013 19 242 52 10.1177/1753425912456223 22904165
9. Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Baydoun AR, Emery PW, Pearson JD, Mann GE, Biochem Biophys Res Commun 1990 173 940 948 10.1016/S0006-291X(05) 80876-9 2268354
10. Arginine in the critical care setting. Zhou M, Martindale RG, J Nutr 2007 137 1687S 1692S 17513448
11. Promising therapies in sickle cell disease. Raghupathy R, Billett HH, Cardiovasc Hematol Disord Drug Targets 2009 9 1 8 10.2174/187152909787581354 19275572
12. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Tangphao O, Grossmann M, Chalon S, Hoffman BB, Blaschke TF, Br J Clin Pharmacol 1999 47 261 266 10215749
13. Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. Bednarz B, Jaxa-Chamiec T, Maciejewski P, Szpajer M, Janik K, Gniot J, Kawka-Urbanek T, Drozdowska D, Gessek J, Laskowski H, Kardiol Pol 2005 62 421 427 15928719
14. Amino acids as modulators of endothelium-derived nitric oxide. Kakoki M, Kim HS, Edgell CJ, Maeda N, Smithies O, Mattson DL, Am J Physiol Renal Physiol 2006 291 297 304 10.1152/ajprenal.00417.2005 16571593
15. A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease. Oka RK, Szuba A, Giacomini JC, Cooke JP, Vasc Med 2005 10 265 274 10.1191/1358863x05vm637oa 16444855
16. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F, Proc Natl Acad Sci U S A 1991 88 10480 10484 10.1073/pnas.88.23.10480 1720542
17. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP, Circulation 2007 116 188 195 10.1161/CIRCULATIONAHA.106.683656 17592080
18. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, et al. JAMA 2006 295 58 64 10.1001/jama.295.1.58 16391217
19. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL, Arterioscler Thromb Vasc Biol 2003 23 97 103 10.1161/01.ATV.0000040223.74255.5A 12524231
20. Continuous exposure to L: -arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells. Mohan S, Wu CC, Shin S, Fung HL, Amino Acids 2011 2011 2011
21. Dihydrobiopterin (BH2): Key determinant in influcencing arginien mediated endothelial tolerance and dysfunction. Mohan S, Patel H, Bolinaga J, Soekamto N, Achu L, Teklemariam K, Am J Biochem Biotechnol 2012 8 54 62 10.3844/ajbbsp.2012.54.62
22. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Hardie DG, Carling D, European journal of biochemistry/FEBS 1997 246 259 273 10.1111/j.1432-1033.1997.00259.x 9208914
23. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. Winder WW, J Appl Physiol 2001 91 1017 1028 11509493
24. AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Reihill JA, Ewart MA, Hardie DG, Salt IP, Biochem Biophys Res Commun 2007 354 1084 1088 10.1016/j.bbrc.2007.01.110 17276402
25. Fluid shear stress and NO decrease the activity of the hydroxy-methylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxO1. Fisslthaler B, Fleming I, Keseru B, Walsh K, Busse R, Circ Res 2007 100 12 21 10.1161/01.RES.0000257747.74358.1c 17218607
26. Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium. Chen H, Levine YC, Golan DE, Michel T, Lin AJ, J Biol Chem 2008 283 4439 4447 18079117
27. Protein measurement with the Folin phenol reagent. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, J Biol Chem 1951 193 265 275 14907713
28. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Xia Y, Zweier JL, Proc Natl Acad Sci U S A 1997 94 6954 6958 10.1073/pnas.94.13.6954 9192673
29. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T, J Biol Chem 2003 278 3170 3175 10.1074/jbc.M209264200 12419811
30. Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS. Shin S, Fung SM, Mohan S, Fung HL, J Chromatogr B Analyt Technol Biomed Life Sci 2011 879 467 474 10.1016/j.jchromb.2011.01.006 21282076
31. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Forstermann U, Munzel T, Circulation 2006 113 1708 1714 10.1161/CIRCULATIONAHA.105.602532 16585403
32. Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells. Zhang J, Xie Z, Dong Y, Wang S, Liu C, Zou MH, J Biol Chem 2008 283 27452 27461 10.1074/jbc. M802578200 18693249
33. Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, Kemp BE, Power DA, Atherosclerosis 2008 200 28 36 10.1016/j.atherosclerosis.2007.12.003 18191860
34. Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Stahmann N, Woods A, Carling D, Heller R, Mol Cell Biol 2006 26 5933 5945 10.1128/MCB.00383-06 16880506
35. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Wohlfart P, Malinski T, Ruetten H, Schindler U, Linz W, Schoenafinger K, Strobel H, Wiemer G, Br J Pharmacol 1999 128 1316 1322 10.1038/sj.bjp.0702921 10578147
36. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway. Hwang TL, Hung HW, Kao SH, Teng CM, Wu CC, Cheng SJ, Mol Pharmacol 2003 64 1419 1427 10.1124/mol.64.6.1419 14645672
37. The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Weber M, Lauer N, Mulsch A, Kojda G, Free Radic Biol Med 2001 31 1360 1367 10.1016/S0891-5849(01)00706-7 11728807
38. Explaining the phenomenon of nitrate tolerance. Munzel T, Daiber A, Mulsch A, Circ Res 2005 97 618 628 10.1161/01.RES.0000184694.03262.6d 16195486
39. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY HSA, Meurer S, Deile M, Taye A, Knorr A, Lapp H, et al. J Clin Investig 2006 116 2552 2561 10.1172/JCI28371 16955146
40. Effects of L-NAME, a non-specific nitric oxide synthase inhibitor, on AlCl3-induced toxicity in the rat forebrain cortex. Stevanovic ID, Jovanovic MD, Jelenkovic A, Colic M, Stojanovic I, Ninkovic M, J Vet Sci 2009 10 15 22 10.4142/jvs.2009.10.1.15 19255519
41. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. Xia Y, Tsai AL, Berka V, Zweier JL, J Biol Chem 1998 273 25804 25808 10.1074/jbc.273.40.25804 9748253
42. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr, Proc Natl Acad Sci U S A 1998 95 9220 9225 10.1073/pnas.95.16.9220 9689061
43. The genes of hepatic glucose metabolism. Granner D, Pilkis S, J Biol Chem 1990 265 10173 10176 2191945
44. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Pilkis SJ, Granner DK, Annu Rev Physiol 1992 54 885 909 10.1146/annurev.ph.54.030192.004321 1562196
45. Galactose-1-phosphate in the pathophysiology of galactosemia. Gitzelmann R, Eur J Pediatr 1995 154 45 49 10.1007/BF02143803 7671964
46. Partial deficiency of galactose-1-phosphate uridyltransferase. Gitzelmann R, Bosshard NU, Eur J Pediatr 1995 154 40 44 8529708
47. Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Hanbauer I, Wink D, Osawa Y, Edelman GM, Gally JA, Neuroreport 1992 3 409 412 10.1097/00001756-199205000-00008 1633278
48. Sodium nitroprusside inhibits N-methyl-D-aspartate-evoked calcium influx via a nitric oxide- and cGMP-independent mechanism. Kiedrowski L, Costa E, Wroblewski JT, Mol Pharmacol 1992 41 779 784 1314946
49. Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine. Mohan S, Fung HL, Int J Mol Sci 2012 13 7521 7531 10.3390/ijms13067521 22837709
50. Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells. Mohan S, Wu CC, Shin S, Fung HL, Amino Acids 2012 43 1179 1188 10.1007/s00726-011-1173-y 22130739